This process may involve adjusting dosage, converting tablets to liquids for easier swallowing, removing allergens like dyes, combining medications into one, or addressing drug shortages
10.1002/14651858.CD003460.pub3 36 SellH.BlherM.KltingN.SchlichR.WillemsM.RuppeF.et al (2013)
The company saw an impressive 56% year-over-year (YOY) boost to revenue, thanks in large part to $12.8 billion in combined sales of its two main GLP-1 agonists, Mounjaro and Zepbound
And there's a paper that I saw maybe six months, nine months ago that actually showed that if you take the ApoE 3/4s and 4/4s...so I'm sure better than I do, a 3/4 genotype just on a hazard ratio is about a 2x increase over the 3/3 in terms of Alzheimer's disease
Martemucci G, Costagliola C, Mariano M, Dandrea L, Napolitano P, DAlessandro AG
LR3 is typically used for longer cycles and systemic growth, while DES is best reserved for short-term, site-specific applications immediately post-training or during injury recovery